Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Sex:
Name of Drug
Generic Name:
Calcium Gluconate
Brand Name:
Apo-Cal
Calci-Chew
Calcarb
Patients Dose:
1000 mg PO
Classification
Pharmacologic:
Mineral Supplements
Therapeutic:
Mineral and Electrolyte
Replacements
Diagnosis:
Age:
Date of Admission:
Height/Weight:
Mechanism of Action
Action:
Essential for nervous, muscular, and skeletal
systems. Maintain cell membrane and
capillary permeability. Act as an activator in
the transmission of nerve impulses and
contraction of cardiac, skeletal, and smooth
muscle. Essential for bone formation and
blood coagulation.
Pharmacokinetics:
ROUTE
PO
IV
ONSET
Unknown
Immediate
PEAK
Unknown
Immediate
DURATION
Unknown
0.5-2 hr
Indication
General:
Treatment and
prevention of
hypocalcemia.
Adjunct in the
prevention of
postmenopausal
osteoporosis.
Patients Indication:
Treatment and
prevention of
hypocalcemia.
Maximum Dose:
2000 mg PO
Absorption: Absorption in the GI tract
requires vitamin D.
Minimum Dose:
500 mg PO
Availability:
Tablets
Injection
Pregnancy Category:
Category C
Source:
Deglin, J. (2011) Daviss
Drug Guide for Nurses (12th
ed.) Philadelphia, FA Davis
Company pp.265-269
Half-life: Unknown.
Source:
Deglin, J. (2011) Daviss Drug Guide for
Nurses (12th ed.) Philadelphia, FA Davis
Company pp.265-269
Side Effects
CNS: syncope (IV only),
tingling.
CV: CARDIAC ARREST
(IV only), arrhythmias,
bradycardia.
F and E: hypercalcemia.
Precautions:
Patients receiving
digitalis glycosides;
Severe respiratory
insufficiency; Renal
disease;
Cardiac disease; OB:
Hypercalcemia mayqrisk
of maternal and fetal
complications; Lactation:
Breast
feeding not expected to
harm infant provided that
serum
calcium levels monitored.
Source:
Deglin, J. (2011)
Daviss Drug Guide for
Nurses (12th ed.)
Philadelphia, FA Davis
Company pp.265-269
Source:
Deglin, J. (2011) Daviss
Drug Guide for Nurses
(12th ed.) Philadelphia, FA
Davis Company pp.265269
Nursing Responsibilities
Before:
After:
Source:
Deglin, J. (2011) Daviss
Drug Guide for Nurses
(12th ed.) Philadelphia, FA
Davis Company pp.265269
During:
GU: calculi,
hypercalciuria.
Drug Interactions:
Hypercalcemiaqthe risk
of digoxin
toxicity. Chronic use with
antacids in renal
insufficiency
may lead to milk-alkali
syndrome. Calcium
supplements, including
calcium-containing
antacids,
mayqrisk of
hypercalcemia
Route:
PO
IV
Source:
Deglin, J. (2011)
Daviss Drug Guide
for Nurses (12th ed.)
Philadelphia, FA
Davis Company
pp.265-269
Contraindication
Hypercalcemia; Renal
calculi;
Ventricular fibrillation;
Concurrent use of
calcium
supplements (calcium
acetate).
Source:
Deglin, J. (2011) Daviss Drug Guide for
Nurses (12th ed.) Philadelphia, FA Davis
Company pp.265-269